Travere Therapeutics, Inc. (TVTX) Reports Material Event to SEC
Filing Details Travere Therapeutics, Inc. (NASDAQ:TVTX) filed a Form 8-K with the Securities and Exchange Commission on July 09, 2026, disclosing a material event. Market Context…
Read more
